Payment overview · 2025
General Payments
$31.11
1 reported records · 1 companies
Healthcare provider profile · identity verified
Omar Blas Diaz, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · CAPE CORAL, FL · NPI 1699008896
Verified facts
What the public records show
CMS Open Payments records show Omar Blas Diaz, ARNP received $31.11 in general payments during 2025 across 1 reported records.
Hologic Sales and Service, LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Hologic Sales and Service, LLC | Unresolved — no canonical attribution shown | $31.11 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $31.11 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| APTIMA Normalized: aptima |
Device | Hologic Sales and Service, LLC | $31.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 428 | 185 |
| Atorvastatin Calcium | Atorvastatin Calcium | 300 | 150 |
| Losartan Potassium | Losartan Potassium | 260 | 113 |
| Diclofenac Sodium | Diclofenac Sodium | 259 | 98 |
| Amlodipine Besylate | Amlodipine Besylate | 236 | 106 |
| Metformin Hcl | Metformin Hcl | 232 | 101 |
| Gabapentin | Gabapentin | 217 | 100 |
| Lisinopril | Lisinopril | 176 | 75 |
| Meloxicam | Meloxicam | 171 | 71 |
| Omeprazole | Omeprazole | 165 | 74 |
| Levothyroxine Sodium | Levothyroxine Sodium | 158 | 72 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 157 | 47 |
| Alendronate Sodium | Alendronate Sodium | 121 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 121 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 47 |
| Chlorthalidone | Chlorthalidone | 114 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 114 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 111 | 55 |
| Famotidine | Famotidine | 107 | 47 |
| Memantine Hcl | Memantine Hcl | 102 | 44 |
| Methocarbamol | Methocarbamol | 98 | 40 |
| Trazodone Hcl | Trazodone Hcl | 98 | 47 |
| Montelukast Sodium | Montelukast Sodium | 94 | 41 |
| Fluticasone Propionate | Fluticasone Propionate | 89 | 38 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 89 | 30 |
| Meclizine Hcl | Meclizine Hcl | 86 | 40 |
| Metoprolol Tartrate | Metoprolol Tartrate | 86 | 40 |
| Azithromycin | Azithromycin | 82 | 70 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | 37 |
| Eliquis | Apixaban | 78 | 29 |
| Baclofen | Baclofen | 77 | 32 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 33 |
| Farxiga | Dapagliflozin Propanediol | 71 | 21 |
| Ibuprofen | Ibuprofen | 71 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 71 | 25 |
| Allopurinol | Allopurinol | 68 | 27 |
| Furosemide | Furosemide | 68 | 36 |
| Mirtazapine | Mirtazapine | 68 | 35 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 24 |
| Glipizide | Glipizide | 65 | 27 |
| Ondansetron Hcl | Ondansetron Hcl | 64 | 26 |
| Jardiance | Empagliflozin | 63 | 28 |
| Simvastatin | Simvastatin | 60 | 34 |
| Lactulose | Lactulose | 56 | 24 |
| Metformin Hcl Er | Metformin Hcl | 56 | 23 |
| Clonidine Hcl | Clonidine Hcl | 52 | 24 |
| Donepezil Hcl | Donepezil Hcl | 50 | 20 |
| Nitroglycerin | Nitroglycerin | 50 | 19 |
| Januvia | Sitagliptin Phosphate | 48 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | 17 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 47 | 19 |
| Atenolol | Atenolol | 47 | 17 |
| Alcohol Pads | Alcohol Antiseptic Pads | 46 | 27 |
| Carvedilol | Carvedilol | 46 | 26 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 45 | 14 |
| Single Use Swab | Alcohol Antiseptic Pads | 43 | 20 |
| Latanoprost | Latanoprost | 42 | 11 |
| Ketoconazole | Ketoconazole | 40 | 13 |
| Xarelto | Rivaroxaban | 40 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 39 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | 17 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 39 | 23 |
| Folic Acid | Folic Acid | 37 | 15 |
| Methylprednisolone | Methylprednisolone | 37 | 29 |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 37 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 37 | 13 |
| Torsemide | Torsemide | 37 | 24 |
| Diclofenac Potassium | Diclofenac Potassium | 36 | 14 |
| Enalapril Maleate | Enalapril Maleate | 36 | 14 |
| Ammonium Lactate | Ammonium Lactate | 35 | 20 |
| Dicyclomine Hcl | Dicyclomine Hcl | 35 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | 13 |
| Celecoxib | Celecoxib | 32 | 18 |
| Fenofibrate | Fenofibrate | 32 | 15 |
| Mometasone Furoate | Mometasone Furoate | 32 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | 14 |
| Clobetasol Propionate | Clobetasol Propionate | 31 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | 15 |
| Sertraline Hcl | Sertraline Hcl | 31 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 15 |
| Ezetimibe | Ezetimibe | 30 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 16 |
| Ozempic | Semaglutide | 30 | suppressed |
| Sucralfate | Sucralfate | 30 | 12 |
| Levofloxacin | Levofloxacin | 29 | 26 |
| Pregabalin | Pregabalin | 29 | suppressed |
| Ciclopirox | Ciclopirox | 28 | suppressed |
| Spironolactone | Spironolactone | 28 | 15 |
| Temazepam | Temazepam | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | 12 |
| Naproxen | Naproxen | 25 | 14 |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 17 |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 22 | 11 |
| Nystatin | Nystatin | 22 | 11 |
| Cephalexin | Cephalexin | 21 | 16 |
| Glimepiride | Glimepiride | 21 | 13 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 21 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 20 | 20 |
| Rizatriptan | Rizatriptan Benzoate | 20 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 20 | 13 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Alprazolam | Alprazolam | 18 | suppressed |
| Finasteride | Finasteride | 18 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Prednisone | Prednisone | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 16 | suppressed |
| Cilostazol | Cilostazol | 16 | 11 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 14 | 12 |
| Risedronate Sodium | Risedronate Sodium | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $31.11 · 1 records | Hologic Sales and Service, LLC | APTIMA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error